SENDERO BIOTECHNOLOGY, INC. — Form D
SENDERO BIOTECHNOLOGY, INC. of ROCHESTER, MI, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-28. The offering totals $7.3M, of which $7.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-28
- Form: D
- Accession: 0001975410-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $7.3M
- Investors: 2
- Date of first sale: 2023-04-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-480333
Issuer
- Name: SENDERO BIOTECHNOLOGY, INC.
- CIK: 0001975410
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 303 E. THIRD STREET, ROCHESTER, MI, 48307
- Phone: 703-405-9113
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Andrew Badley | Director | Rochester, MI |
| Joshua Barer | Director | Rochester, MI |
| Michael Cola | Director | Toronto, A6 |
| Gloria Olivier | Director | Rochester, MI |
| Michael Cola | Executive Officer | Toronto, A6 |
More